You are here: Industry Insights > Gene

News List

B-MoGen Biotechnologies and CytoSen Therapeutics partner on research collaboration to develop next generation Natural Killer Cells pharmafocusasia
January 25, 2019
B-MoGen Biotechnologies, Inc. and CytoSen Therapeutics announced today a research collaboration to develop the next generation of gene-modified Natural Killer Cell (NK) therapies.....
Gene-Linked Iron Disorder More Common Than Thought: Study drugs
January 17, 2019
The most common genetic disorder among northern Europeans -- called hemochromatosis -- occurs more often than previously thought, according to a new study.....
Could blocking a single gene cure obesity without diet and exercise? fiercebiotech
January 02, 2019
One of the biggest obstacles that obese people face as they try to lose weight is struggling to stick with diet and exercise plans. Scientists led by Flinders University in ......
Neurimmune’s anti-SOD1 antibody shows promise in ALS mouse studies fiercebiotech
January 02, 2019
Mutations in the gene SOD1 can cause the enzyme it encodes to fold in ways that are harmful to neurons—an abnormality that's responsible for about ....
U.S. FDA approves Larotrectinib, the first TRK inhibitor, for patients with advanced solid tumors harboring an NTRK gene fusion worldpharmanews
November 29, 2018
The U.S. Food and Drug Administration (FDA) has approved larotrectinib, the first oral TRK inhibitor, under the brand name Vitrakvi®.
US approves first ever TRK inhibitor pharmatimes
November 28, 2018
Bayer and Loxo Oncology’s Vitrakvi has become the first ever TRK inhibitor to be approved in the US, having been cleared to treat advanced solid tumours harbouring an NTRK gene fusion.
Gene editing shows promise in treating inherited kidney disease fiercebiotech
November 20, 2018
Joubert syndrome, an inherited brain disorder that affects one in 80,000 newborns, causes kidney failure in about a third of patients, many of whom end up requiring a transplant or dialysis. This inherited form of kidney disease is caused by a mutation in
Mundipharma to bring world's first gene therapy for knee osteoarthritis .biospectrumasia
November 20, 2018
Mundipharma will be responsible for the development, marketing and distribution of Invossa to medical professionals and
NHS Genomic Medicine Service: the UK seeks to build a global genomic hub pharmaceutical
November 19, 2018
Hot on the heels of the success of the NHS’s 100,000 Genomes Project, which is currently 70% complete and expected to be finished by the end of 2018, NHS England will launch the NHS Genomic Medicine Service in October this year...
SMi presents the launch of Cell & Gene Therapy 2018 worldpharmanews
May 23, 2018
SMi introduces their inaugural event on Cell & Gene Therapy which takes place between the 10th and 11th October 2018, with an interactive pre-conference workshop on the 9th October.

Previous page 1 2 3 4 5 6 7 8 9 10 Next page